Treatment of PCOS Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What is the metabolic defect associated with PCO?

A
  • The central feature is insulin resistance (IR) (aka pre-diabetes).
  • Progresses from normal to impaired glucose tolerance to diabetes and then progression of diabetes.
  • Average weight gain in UK with age is 0.5kg/year
  • Insulin resistance does not form part of the Rotterdam criteria, but it is very much prevalent. Some of it could be in parallel just with increasing levels of obesity in worldwide populations, but some of it is intrinsic to PCO itself.
  • After a meal, food enters the stomach and is digested so blood glucose increases. Insulin is released from the pancreas. It regulates blood glucose; taken up by muscles and organs (some is converted into glycogen). Blood glucose is very tightly controlled by insulin.
  • During insulin resistance, insulin is released but body can’t use it effectively (resistant to the effects) to get rid of the blood glucose, so body produces more. Someone with insulin resistance requires more insulin to get rid of the blood glucose compared to someone without. Initially, they will have hyperinsulinaemia and glucose levels will be normal because the body is trying to maintain homeostasis (trying to keep its normal levels of glucose but needs more insulin to do so). Eventually, things will change.
  • With IR, body is producing insulin but not able to use it effectively (i.e. muscle, fat and liver). To keep blood glucose in normal range, beta-pancreatic cells produce more and more insulin = hyperinsulinemia. Blood glucose is initially normal and insulin levels are high. In Pre-diabetes and T2D, patients develop hyperglycemia because glucose levels can not be maintained.
  • Circulating levels of insulin initially increase to try and maintain euglycaemia (steady glucose levels). Then, it doesn’t work so well; the action is decreasing, and the glucose levels increase. Eventually, there is disruption, or the beta cells get fatigued and don’t produce more insulin (system is broken). This is when the patient converts and becomes diabetic.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does insulin insensitivity correlate to weight?

A
  • Although everyone becomes more insulin resistant with increasing weight, insulin sensitivity declines at a faster rate in women with PCOS than in women with normal ovaries with increasing weight
  • Average weight gain in UK with age = 0.5kg/year
  • Plot of insulin sensitivity against weight shows direct correlation, i.e. as weight increases, insulin sensitivity decreases, but it is a more rapid decline in women with PCO, i.e. at the same weight, the IS in women with PCO is half that of women with normal ovaries
  • Women with PCO will have a lower insulin sensitivity than women with normal ovaries. Even though weight gain predisposes people to become insulin resistant, PCOS speeds up the whole process and makes it worse quickly.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the link between PCOS and adiposity?

A
  • In the USA, obesity affects 80% of women with PCOS & in rest of world 50% (Endocrine Reviews (2015) 36)
  • Women with PCOS have central adiposity, which is linked to IR). Used to think it was more visceral fat (around the organs; more dangerous, produces inflammatory cytokines and inflammatory mediators). This was contradicted by some studies that used good scanning techniques to be able to measure this; literature is very contradicting. May NOT be due to higher relative percentage of visceral fat!
  • In animals, exposure to androgens is associated with increased fat accumulation (Maliqueo et al (2013) Endocrinology 154:434-45). E.g. seen in macaque monkeys and sheep model.
  • In transsexuals, when they have to be treated with androgens to induce masculinity in the female to male transsexual, it increases fat accumulation around the organs, so androgens are a contributing element. Treatment with high androgens in female-to-male transsexuals increases visceral fat accumulation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Outline the molecular mechanism of IR in PCOS.

A
  • Insulin resistance is familial (within families = familial traits), but no mutations in insulin receptor gene has ever been found in PCOS.
  • Therefore, it is likely to be a post-receptor binding defect somewhere in signalling pathway of granulosa cells.
  • In general, systemic insulin resistance in the body, it is a defect in the signalling in the muscles, fat and in other tissues. This is why glucose is not taken up effectively. Even though insulin binds to its receptor on these tissues, it does not do the downstream signalling events properly to allow glucose to be taken up into the cell. For a long time, people thought the ovary was exempt from this because steroid output was normal. However, research suggests it is a post receptor binding defect; it maintains a steroid pathway, but it affects glucose metabolism.
  • Thought to be a situation whereby insulin could bind to its receptor but in insulin resistance, this signalling pathway which allows for GLUT4, a vesicle that must be inserted into the membrane to allow glucose entry, has a defect somewhere along it.
  • From a lot of other tissues, adipocytes and skeletal muscles, we know that in insulin resistance, as well as having a defect in this pathway which eventually results in glucose entering, macrophages and cytokines will contribute to it. Insulin resistance leads to a lot of inflammation, because the fat is associated with inflammation. A lot of those inflammatory markers also contribute to this dysregulation in the pathway (double whammy of effects).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the effects if obesity on PCOS?

A
  • Obesity exacerbates many aspects of PCOS (clinical, hormonal and metabolic features in women). This becomes part of the problem. Often, girls will have PCOS-like traits/be prone to it from adolescence, but they are not followed up or taken seriously (especially irregular periods). A lot of girls stop doing any form of exercise after entering puberty (due to becoming more body conscious); with traits of PCOS, the girls are more prone to putting on weight. Exponential increased risk.
  • If patient has oligomenorrhea & hyper-androgenism in adolescence then increased risk of developing obesity & MetS by 24y
  • These women are prone to problems by 24/25 years old, all related to obesity, insulin resistance and metabolic syndromes.
  • 30-40% women with PCOS have impaired glucose tolerance (IGT) and 10% develop T2DM by age 40yrs
  • Higher incidence of T2DM in women with family history i.e. Indian sub-continent Asians. T2DM is very prevalent in Indian sub-continent Asians, as is PCOS, and having a family history increases the risk.
  • While the clinical consequences are not about death, they are still significant and awareness is important.
  • Obesity & insulin resistance results in increased incidence of gestational diabetes (GDM) if pregnant with PCOS. It presents first in pregnancy due to how the foetus behaves and it is the foetus who can make the mum insulin resistant.
  • Unpublished data shown that nearly all women with GDM had PCO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the gold standard test used to measure impaired glucose tolerance?

A
  • Oral glucose tolerance test to determine IGT = Begin by fasting 8-12h before test (usually overnight) → glucose given as a solution → blood samples taken at regular time points over the next two hours to determine how quickly glucose is cleared from blood
  • Normal = Fasting value (before test): <6 mM;
    At 2 hours: <7.8 mM
  • Impaired = Fasting value (before test): 6.0 -7.0 mM; At 2 hours: 7.9-11.0 mM
  • Diabetic = Fasting value (before test): >7.0 mM;
    At 2 hours: >11.0 mM
  • It is not always easy to administer and it is time consuming, so not always carried out in routine clinical practice.
  • If someone did not have insulin resistance (normal insulin sensitivity), their fasting glucose levels should be around less 5.6mM before their test. By two hours, it should be less than 7.8mM. Normally, by two hours, it is back to below 5.6mM but this is the limit.
  • If someone was starting to get insulin resistance, so glucose tolerance is impaired, then their fasting glucose value is a bit higher than normal even before the test. After two hours, it still would not come back down to normal. This shows that the body is not able to clear the glucose, so glucose tolerance is impaired because the body is resistant to the effect of insulin (insulin resistance).
  • If diabetic, glucose values are very high before the test and they remain over 11 or 12 mM even after the test.
  • These are the principles of the oral glucose tolerance test used to assess impaired glucose tolerance and insulin resistance.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does the foetus make the mother insulin resistant in gestational diabetes mellitus?

A
  • Hormones produced by foetus can induce insulin resistance in mother.
  • The placenta will produce oestradiol, cortisol, human placental lactogen → HPl interferes with insulin receptors → Maternal Hyperglycemia (fetus makes mum IR, resulting in hyperglycemia in maternal circulation) → Increased glucose in maternal circulation crosses to foetal circulation → Increase in fetal insulin → Excess fetal growth – large for gestational age.
  • If the mom already had insulin resistance or impaired glucose tolerance, it will be made worse, and the mother will become diabetic during pregnancy. Increased glucose occurs in the maternal circulation and this crosses into the foetal circulation, causing other problems for the foetus eventually. . HPL drops after delivery. Glucose travels freely from the mother to the foetus, but maternal insulin does not. Thus, maternal gestational diabetes exposes the foetus to higher concentrations of glucose than normal, which force the foetus to increase its own insulin production. Unfortunately, excess insulin produced by the foetus in response to the mother’s gestational diabetes can cause the foetus to grow excessively, a condition known as large for gestational age. For foetus they are large for age and low blood sugar and increased risk of childhood obesity.
  • It is a two-way thing; the placenta produces all these hormones which then interfere with the maternal glucose clearance. There is high glucose in circulation, and this feeds back to the foetus. This affects the foetus and can cause things like increasing foetal insulin, which can cause excess foetal growth and result in big babies.
  • Normally, once the baby has been delivered, HPL levels will fall, and normal insulin sensitivity resumes in most cases. Often, if a mom has had gestational diabetes in one pregnancy, she is prone to getting it in the next pregnancy. Also, it can long-term postnatally cause problems for the foetus itself then.
  • There are issues with big babies and various complications associated with GDM.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the complications of GDM for mother & foetus?

A
  • Even if glucose goes back to normal after pregnancy, have an increased risk of T2D
  • If already IR and then pregnant, it induces increase in GDM risk, pre-eclampsia and later T2D.
  • Unpublished data showed that nearly all women with GDM had PCO.
  • The oral glucose challenge test (OGCT) is a short version of the OGTT, used to check pregnant women for signs of gestational diabetes. It can be done at any time of day, but not on an empty stomach. The test involves 50g of glucose, with a reading after one hour.
  • If the birth weight is very big, it’s not very healthy for the baby; baby can get trapped in the birth canal during delivery, Can trigger pre-eclampsia and premature delivery. All very serious complications.
  • Percentage increase in odds of complications with GDM:
    1) Birth weight >90th percentile = 38%
    2) Shoulder dystocia (birth injury) = 22%
    3) Premature delivery = 16%
    4) Preeclampsia = 28%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the correlation between IR and anovulation?

A
  • There is a direct inverse relationship between hyperinsulinemia and ovulation rate.
  • Also known that high insulin levels can have a detrimental effect on follicles.
  • Insulin resistance is also linked to anovulation. Inverse correlation graph; as serum insulin levels increase, the number of cycles decrease.
  • More severely insulin resistant = less menstrual cycles (increased chances of becoming anovulatory)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the other manifestations of metabolic defect in PCO?

A
  • tendency to obesity with increase in truncal-abdominal fat
  • increased hypertension (variable)
  • Altered lipid profile = higher levels of LDL cholesterol – regardless of BMI, low levels of HDL cholesterol and elevated triglycerides
  • apparent increased risk for atherosclerotic disease
    1) Increased coronary artery calcification (independent of age & BMI)
    2) Increased carotid artery intima-media thickness (predictor of stroke & MI) compared to age-matched controls
    3) Limited longitudinal studies → PCOS diagnosed during reproductive lifespan (20-30 years old) but CVD manifests 30 to 40 years later.
    4) Also majority of conducted research on CVD on male →concept that women present differently
  • Recent study showed that women with PCOS at ↑risk of osteosarcopenia (Kazemi M et al (2020) JCEM 105:e3400-e3414)
  • Limited longitudinal studies re. CV risk factors, but indications are there. Osteosarcopenia is a newly described syndrome that describes the co-existence of osteoporosis and sarcopenia, two chronic musculoskeletal conditions associated with ageing. Osteoporosis, a condition of low bone mass and micro-architectural deterioration of bone, and sarcopenia, the loss of muscle mass, strength and function, often co-exist in a frail subset of the elderly population, leading to significantly worsened outcomes than seen in either condition alone.
  • Increased tendency to obesity with the deposition of fat around the truncal-abdominal area (apple-shaped)
  • All of the associations of metabolic syndrome, e.g. increased hypertension, altered lipid profiles
  • Lots of controversy about whether there was an increased risk for atherosclerotic disease (cardiac disease). It was debateable because it could not be diagnosed. Does not present in woman until their 60’s/70’s (quite a while after menopause because oestrogen is thought to be protective of CVD). It is difficult to look at women in their 60’s/70’s, because there was no diagnostic method for PCOS when they were in their 30’s. Longitudinal studies to follow them up have been difficult; just started to come out now and there are indicators of increased risk of CVD.
  • Osteosarcopenia = combination of osteoporosis and muscle degeneration
  • This is not something that just ends when reproductive life finishes; the effects have consequences post menopause for a lot of women.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why do women with PCOS gain weight? Are women with PCOS more inclined to put on weight or is it parallel to growing obesity epidemic?

A
  • Constant tendency to gain weight
  • Normal-weight women with PCOS consistently maintain a lower-calorie diet than their over-weight counterparts
  • HRQoL study in women with PCOS → normal-weight women experienced as many problems with their weight as obese women. HRQoL = health related quality of life.
  • PCO is associated with reduced energy expenditure equivalent to over 17,000 kcal/pa. Can live on less calories with PCO than normal.
  • When putting two groups on matching low-calorie diets, where one group has PCOS and the other doesn’t, women who have PCOS will lose weight slower than women with normal ovaries. This shows that there is something intrinsic about having PCOS which predisposes women to gaining weight. One of the important factors is reduced energy expenditure. It also relates to the food available nowadays, e.g. processed food, additives. This alters the environment in the body and how calories are handled, but women also have this intrinsically reduced energy expenditure. This is due to reduced post-prandial thermogenesis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does post-prandial thermogenesis differ in PCOS?

A
  • PCOS is associated with reduced energy expenditure
  • this is due to reduced post-prandial thermogenesis (PPT)
    it is amplified by obesity in PCOS
    Insulin sensitivity is reduced in both obese & lean women with PCOS compared to normal
  • The diff in PPT between normal and PCO is small if lean, but half if obese.
  • PPT = following a meal (after eaten)
    Thermogenesis = body’s normal ability to burn off the calories from a meal. This is in the normal processes of the body’s functions.
  • Reduced energy expenditure predisposes them to gain weight.
  • The graph shows that in women who are weight matched, women with PCOS have slightly decreased PPT. This means that they must work harder to maintain that same weight. Looking at obese women, can see that woman with PCO have half the postprandial thermogenesis. Even women who are lean have slightly reduced PPT, meaning they have to work harder than their normal counterparts to maintain their weight, but this gets worse (even harder to lose weight) if weight is put on.
  • Insulin sensitivity is decreased; one thing feeds in to the other.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does reduced PPT result in weight gain?

A
  • As there is a deficit in how calories are burned, a small amount of weight is put on from the age of 15. Because you are prone to it (since it coincides with girls stopping exercise at school), then weight gain is quite a lot by the time they think about conceiving. This will then have a negative effect on the menstrual cycle, on ovulation. This feeds into that. Therefore. it is important to start interventions with adolescent girls. Often, the focus may be on the external presentation (hirsutism or acne), but the woman/girl needs to be treated as a whole, looking at all of the parameters; the problem with PCOS is that everyone treats each symptom as it presents individually.
  • If PCOS is associated with so many negative things, why does it persist in the population (especially if it is a polygenic disease; there are many genes that predispose us to PCOS)?
  • If you go and see your GP in your teens, they usually tell you to go away and come back when you want a baby, or your cycles will settle down in a bit. By the time the patient is in their 20s they’ve put 1.9kg/year (17,200 calories p.a.) which complicates the situation and make it very hard to lose weight, get regular cycles etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How are SHBG levels affected in PCO?

A
  • SHBG, sex hormone binding globulin, binds androgens and that determines free androgens. Vast majority of testosterone is bound to SHBG.
  • Small change in SHBG causes large change in free testosterone
  • SHBG dependent on BMI ie obesity ↓SHBG & ↑free T
    SHBG is dependent on BMI. If BMI increases, it decreases as SHBG production from the liver and increases testosterone. The graph shows that in woman with BMI over 25 who have PCO, their SHBG is almost half of the normal (even though the normal population includes all of the weights). This proves that if SHBG is low, free testosterone is high. The effects and symptoms of testosterone are then known.
  • SHBG production by liver is also inhibited by insulin (not just linked with high BMI)
  • Insulin also stimulates ovarian androgen production (synergises with LH)
  • Hyperinsulinemia will also reduce SHBG. Insulin is also a cogonadotrophin with LH, stimulating it to increase testosterone. Hyperinsulinaemia makes the androgen problem worse by driving the ovary to make more A but also by increasing free androgens.
  • In normals, the androgens are low anyway so even if reduce SHBG the increase in androgens is not very much. In PCO and with higher BMI, have half the amount of SHBG and so increases the androgens even further.
  • Overall, increase in testosterone!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Summarise long-term outcomes for women with PCOS.

A
  • Putting it all together, in the lifespan of a woman with PCOS, the insulin levels initially rise exponentially with increasing weight, resulting in increasing IR. The increased insulin drives increasing androgens and also decreases SHBG – make hyperandrogenism worse. All increase’s anovulation. As age, then insulin struggling to keep pace with IR, results in glucose intolerance. If you conceive then will get GDM and in 40-50s will get T2D and CVD.
  • The long-term outcome for women with PCOS = they gain weight because they have reduced PPT, their bodies are geared up with the insulin resistance to also increase their weight etc. With increasing weight, the women are more prone to insulin resistance, which just gets worse with weight increase. Insulin resistance presents as high insulin initially and will then convert to type 2 diabetes before insulin levels drop off. High insulin will augment androgen secretion, which increases the total androgen secretion. High insulin decreases SHBG, which then again increases free androgens, increasing hirsutism and acne. It is also linked with anovulation. As weight gain increases and insulin increases, all those effects can cause problems ovulating. Pregnant with PCOS means the woman is more prone to getting gestational diabetes. Later in life, they can get type 2 diabetes. It also seems that there is a risk of CVD. The long term outcome for women with PCOS are not great with all of the complications.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the Endocrine Society Clinical Guidelines for Treatment of PCOS?

A
  • No “cure” = treatment is symptomatic. Treat the symptoms as and when they appear.
  • Lifestyle intervention and weight loss improves overall PCOS status in overweight/ obese patients along with other health benefits eg insulin resistance, CVD
  • First line management for menstrual abnormalities and hirsutism/acne in PCOS are hormonal contraceptives (HC)
  • First line therapy for infertility is Clomiphene
  • is beneficial for metabolic/glycaemic abnormalities & for improving menstrual irregularities, but of limited benefit in treating hirsutism, acne or infertility. Metformin is an insulin sensitiser. Does not really work against hirsutism, infertility or acne.
  • That is a cohort of women who are very lean with PCOS and they are the most difficult to treat. PCOS is a spectrum; there are some women who present with PCOS and often, when they lose a little bit of weight or improve their fitness (insulin status and weight is not always linked, e.g. muscle can cause heavier weight but better insulin sensitivity), these women can’t do anything because they can’t be expected to lose weight and they maintain their weight. They are anovulatory and difficult to treat.
17
Q

Describe a study that looked at the effects of lifestyle interventions in PCOS.

A
  • First line treatment to improve insulin resistance =
    diet and exercise
  • 24 women on very calorie-restricted diet (1000 calories). Target was to lose 5% of body weight (Kiddy et al, 1992, Clin. Endocrinol. (Oxf) 36:105-11)
  • Results: Of the 13 who succeeded = 5/7 conceived, 11 who didn’t = 1/8 conceived
  • Subsequent trials shown that if overweight/obese women with PCOS have 5-15% weight loss then significant improvement in following parameters (Harrison CL et al, 2011, Hum. Reprod. Update 17:171-83)
    1) Serum lipids
    2) Serum T and SHBG
    3) Glucose tolerance and fasting insulin
    4) Hirsutism
    5) Ovulation and menstrual cycle regularity
  • This was one of the first studies to show the importance of diet and exercise (quite old now). Put women on a very calorie-restricted diet. Very few participants as it was difficult to carry out.
  • Showed that even a small percentage drop in body weight helps make menstrual cycles more regular.
  • Should consider age; can’t dismiss people in their late 30’s/early 49’s and tell them to lose weight before looking into fertility treatments (due to ovarian physiology).
  • Studies from Australia show diet is as successful as medical intervention (Anne Clarke) but drop-out rate high » requires support system and frequent attendance and exercise programme
  • Weight loss helps, but exercise is very useful because it improves insulin sensitivity.
18
Q

How is obesity tackled in PCOS?

A
  • Weight loss notoriously hard to achieve
  • Orlistat, marketed as alli, and other drugs are lipase inhibitros, so increase fat in stools - get anal leakage! Reduces uptake of fat from bowel and increases it in stools – side effects of anal leakage. Fat is broken down into triglycerides and smaller components. This is taken up across the bowel into the bloodstream. Orlistat binds to those fat molecules and prevents them from being taken up, thus increasing the fat in stools. Side effects aren’t pleasant.
  • For morbidly obese (BMI>40), bariatric surgery has been proven to be very effective.
  • Meta-analysis of 2130 women who had bariatric surgery:
    1) 46% identified as having PCOS pre-op → dropped to 7% one year post-op (p<0.001). As soon as the 46% of women who identified as having PCOS had bariatric surgery and reduced their weight, only 7% of them remained in the PCOS.
    2) Incidence of hirsutism pre-op was 67% & dropped to 39% one year post-op (p=0.03)
    3) Menstrual irregularity was 56% pre-op and dropped to 8% one year post-op
    4) Pre-op fertility was 18% and post-op was 43%
    Skubleny D et al (2016) Obes.Surg. 26:169-176
  • When women are in this category, bariatric surgery is very effective. The surgery can be expensive, but it will probably be quite cheap in the long run if they can keep the wight off (which they usually can, so they probably won’t get all the negative effects).
19
Q

How is IR treated in PCOS?

A
  • Diabetes drugs such as metformin
  • Metformin is a biguanide (insulin sensitiser)
  • Decreases hepatic glucose production therefore less in serum
  • Enhances glucose uptake into muscle
  • Increases oxidation by adipose tissue
  • Metformin has become very popular to be used for PCOS, though is technically not licensed
  • Anecdotal how it came about to be used since women were insulin resistant. Metformin stabilizes the body by improving aspects to get rid of glucose without affecting insulin production. A lot clinicians were putting their patients on metformin to help them with insulin resistance. They found that those women who were having irregular cycles were starting to have regular cycles/ovulate and get pregnant. It became the go to drug for PCOS, but really it has to be treated sensibly and there have been a lot of different studies.
20
Q

How is metformin used in the treatment of PCO?

A
  • Recent recommendations for use of metformin in women with PCOS who have T2DM or IGT who fail lifestyle interventions
  • Improvement in ovulation rates on metformin (Tang et al, Cochrane Review (2012); Endocrine Society Clinical Practise Guideline for PCOS)
  • Metformin is 2nd-line treatment for women with PCOS who have menstrual irregularities and cannot tolerate HC
  • Adjust dose for different body weights
  • Metformin may be of use to treat gestational diabetes
  • Recommended for use in adolescents with PCOS
  • Metformin won’t really work in women with a really high body weight.
  • For women within a certain range, it will improve ovulation rates.
  • Quite good for women who can’t tolerate the oral contraceptive pill and it is the recommendation for adolescents with PCOS.
  • Trials are currently going on to see use in gestational diabetes; known it is safe.
21
Q

How is hormonal contraception used as treatment for menstrual irregularity?

A
  • irregular cycles i.e. oligo/amenorrhoea; Have follicles, just acyclical and not ovulating.
  • unlike many women with amenorrhoea, women with PCO are well-oestrogenised. Arrested antral follicles keep producing oestrogen, so women with PCO are well-oestrogenised unlike many women with amenorrhoea (there are no follicles in other anovulatory disorders). Can actually get over-oestrogenised without ovulation, progesterone, CL etc. (keep producing oestrogen without the cyclical rise and fall, so there is a risk of endometrial hyperplasia).
  • Aim for minimum of 4 ovulations per year to avoid endometrial hyperplasia
    HC pill first line treatment for menstrual abnormalities
    1) Important to limit endometrial hyperplasia and menorrhagia. Endometrial hyperplasia = lining of the womb grows overly thick. Want the lining to be shed to prevent endometrial hyperplasia (risk of different problems). Menorrhagia = excess bleeding; if the endometrium gets too thick, it will slough off and bleed excessively. Also, there is a risk of endometrial cancer if the endometrium is allowed to keep growing without shedding.
    2) Increased risk of endometrial CA with prolonged amenorrhoea in PCOS as well-oestrogenised
    3) Progestins in HCs suppress LH levels and hence ovarian androgen production
    4) Avoid androgenic progestogens
    5) Risk…appetite stimulant so need advice regarding weight gain
  • OCP if not looking for fertility. The oral contraceptive pill is the first line of treatment. Want to use a type of pill that doesn’t increase androgen production or have androgenic properties. Suppressing LH has the bonus of suppressing LH.
22
Q

How does PCOS increase the risk of endometrial cancer?

A
  • Even when amenorrhoeic, women with PCOS are well-oestrogenised
  • Unopposed oestrogen on endometrium → risk factor for hyperplasia
  • Risk factor of endometrial cancer is probably exacerbated by obesity
  • Recent meta-analysis showed 3 fold increased risk of endometrial CA…even under 50 (Chittenden et al, (2009) Rep.Biomed.Online)
  • Another study found an increase only in obese women with PCOS (Fuberg & Thune (2003) Int. J. Cancer)
  • Recommendation to have bleed at least every 3 months, more often if very heavy.
  • A lot of women go on the pill to regularize this which does its job.
23
Q

What are the cutaneous manifestations of PCOS?

A
  • Hyperinsulinemia from IR acts at dermis to induce acanthosis nigricans and skin tags. Acanthosis nigricans is a disorder that may begin at any age. It causes velvety, light-brown-to-black, markings usually on the neck, under the arms or in the groin. Acanthosis nigricans is most often associated with obesity. Most patients with acanthosis nigricans have a higher insulin level than those of the same weight without acanthosis nigricans. Elevated levels of insulin in most cases probably cause acanthosis nigricans.
  • The elevated insulin levels in the body activates insulin receptors in the skin, forcing it to grow abnormally.
  • Treatment to just improve the appearance includes tretinoin, 20% urea, alpha hydroxyacids, and lactic or salicylic acid prescriptions.
24
Q

What is the Ferriman-Galway score used for and what needs to be considered?

A
  • 75% women with hirsutism/acne have PCO
  • even higher in women with h/a and oligomenorrhoea
  • consistently reported as most distressing symptom
  • cause of significant reduction in quality of life by questionnaire, cause of low-self esteem
  • Hirsutism assessed by Ferriman-Galway score (ethnic differences)
  • > 80% of patients presenting to dermatology clinic for acne had PCOS
  • One criticism of the Ferriman-Galway score = was it only designed/validated for the Caucasian population? Now different scores are being brought in to take different ethnicities into account and the predisposition in that population.
  • Women often do not know they have PCOS; they can be referred from different clinics due to the variety of symptoms. First link is often missed.
25
Q

Describe the spectrum of presentation associated with PCOS.

A
  • Androgenic alopecia = less frequent and presents later, but very distressing with significant psychological comorbidities. Poor association with biochemical hyper-androgenism, maybe associated with IR and metabolic syndrome
  • Acne
  • Hirsutism
  • Central adiposity
  • Obesity
26
Q

Summarise hirsutism/acne treatments.

A

1) Medical management with/without other therapies:
- COCP with non-androgenic progesterone eg deogestrel*
- COCP with androgen blocking diuretic effect eg drospirenone*
- Anti-androgens eg cyproterone acetate, ethinyloestradiol, spironolactone (monitor renal function), finasteride (post-menopausal), flutamide
- GnRH therapy – very severe acne only. GnRH therapy is very specialised and only in extremely severe, infected acne to suppress ovary – 6 months only
- BSO = bilateral saplingo-oophorectomy (after had children) for those desperate and after child birth, but will then become menopausal ie removing ovaries AND tubes. Very extreme measures that are often not taken.

2) Other therapies:
- Weight reduction
- Physical therapies – electrolysis, laser hair removal, waxing, shaving, plucking
- Topical treatments: eg eflornithine 11% for facial hair**
Isotretinoin (popular drug used to treat acne) but not recommended in PCOS. Isotretinoin therapy not only fails to produce the desired clinical effect but contributes to an increase in body weight and triglyceride levels in the pa-tients.27 Due to the high costs, the multitude of potential adverse effects and its problematic effectiveness, isotretinoin treatment is not yet widely recommended in PCOS, although the prospects are promising.
- Psychological intervention
- Androgenetic alopecia – 2% solution minoxidil used 2x/day for 6 months

  • If hirsutism/acne too severe for COCP, then use anti-androgens to block AR.
  • Remember because of feminising effect on male fetus, need to give CA as contraceptive.
  • higher risk of thrombosis
    • not for pregnant women or those trying to conceive
27
Q

What are mechanical treatments?

A
  • Can do physical removal by electrolysis or laser. Have to be done privately, have to pay and can be very expensive.
  • Takes a lot to get rid of hair. The hair follicle cycle is very long, so the process is also long to get rid of it.

1) Electrolysis
- Electrical current causes high temperature in hair shaft
- Must destroy dermal papillae to prevent regrowth
- Not really practical for large areas
- Often worth removing hair by another means a short while before, then growing hairs can be focussed on.
- May be best combined with medical treatment

2) Laser
- heat destroys the hair follicle. Need dark pigment to absorb the heat of the light/laser
- Needs dark hair on light skin
- Not often available on NHS
- Hair follicle cycle is long → many sessions

28
Q

How does Vaniqa (Eflornithine) treat hirsutism?

A
  • Topical cream inhibits enzyme, Ornithin Decarboxylase, that is needed for hair shaft growth.
  • Must be applied 2x day every day
  • Grows back as soon as stop use
  • Can be bought online without a prescription
29
Q

How is infertility treated in PCOS?

A
  • Weight reduction is primary goal in the overweight
  • Increased chance of spontaneous ovulation
  • Reduced chance of miscarriage
  • Need less drugs for induction of ovulation
  • Reduction in GDM
  • Improved outcome for baby
  • Improved long term outcome for patient
  • Low calorie diets seem to work best.
  • Even a 5% reduction in weight is sufficient to improve endocrine function
  • Time is an important factor; if time is on your side, this is a good route to down (improves outcomes for you and baby).
30
Q

How can ovulation be induced to treat infertility in PCOS?

A
  • First line of treatment usually.= induction of ovulation.

1) Clomiphene Citrate i.e. anti-oestrogen (1st line)
- raised acyclical oestrogen results in disordered pituitary LH and more importantly FSH
- Although oestrogen levels aren’t too high, there isn’t the cyclical rise and fall that occurs in the normal cycle. This constant kind of low to elevated levels of oestrogen affects feedback (pituitary LH and FSH). The aim of using Clomid (clomiphene) is to impair that feedback; remove the negative feedback and allow the intercycle rise in FSH for follicle recruitment.
- given for 5 days to mimic inter-cycle rise in FSH
- CC is a SERM (selective oestrogen receptor modulator) and binds to ER in hypoth/pit. Removes negative feedback, allowing for GnRH & FSH release. It binds to oestrogen receptor, occupies it and prevents the body’s oestrogen from acting on it. This prevents that negative feedback and allows FSH to rise. Have to be careful when using it because a large rise in FSH can occur and recruit a lot of follicles (many arrested follicles are present).
- 70-90% responders in the best hands
- The women are then at risk of getting other complications. Risk of multiple pregnancy = ~10% (there are a lot of big follicles growing). If the man has normal sperm, they will put the women on Clomid and monitor but warn not to have intercourse during this time until told due to the risk of unwanted pregnancies.
- high miscarriage rate (up to 40%)
- risk of multiple follicles/ ovulation & OHSS…ultrasound monitoring 1st cycle. OHSS = ovarian hyperstimulation syndrome.
2) Metformin + CC
- Improves clinical pregnancy rates but not live birth rates
- It was found that using metformin and clomid produces a better response (without the crazy overresponse; modulates it a bit), but the miscarriage rate is still the same.
3) Aromatase inhibitors (e.g. Letrozole)
- Same effects as the anti-oestrogen but inhibits production of oestrogen (Legro et al, NEJM (2014) 371:119-129)
- Letrozole (also used in breast cancer treatment) inhibits aromatase, hence oestrogen production, so does the same thing. However, clomid acts as an anti-oestrogen because it binds to the ER to prevent oestrogen acting while aromatase inhibitors actually prevent oestrogen production.

4) FSH treatment
- Daily injections of FSH: aim for single follicle. FSH is used due to the constant negative feedback. Allows the follicles to grow up.

31
Q

How is AMH associated to induction of ovulation?

A
  • Interesting study that came out recently and used many participants.
    748 women with PCOS and anovulation (18-40 years)
    1) AMH measured at baseline
    2) Treated with clomiphene citrate or letrozole for 5 days per cycle & for 5 cycles
    3) AMH levels significantly lower in women who achieved ovulation vs women who did not overall and also within each treatment group
  • High serum AMH associated with a reduced response to ovulation induction among women with PCOS women with higher AMH levels need higher doses of ovulatory medication to achieve ovulation. In normal ovaries, AMH levels decrease in follicles >9mm which is important to allow for DF selection
  • PCOS is diagnosed by exclusion; There are lots of tests that need to be run and in order to keep the costs down, IVF clinics don’t want to run all of these tests. However, screening all women for PCOS and measuring AMH would allow a standardised cut-off level to be formed (can measure chances inducing ovulation).
32
Q

How and why is ovarian laser diathermy/ovarian
puncture or wedge resection
conducted?

A
  • Many years ago, wedge resections used to be carried out. Pieces of ovary were cut out and women would then start ovulating. A surgeon had the idea to revisit this using laser diathermy.
  • ovary “drilled” laparoscopically with laser
  • mechanism of action unknown → may act by destroying stroma, reducing size of matrix and lowering endogenous androgen production
  • Return of cycles for up to 6 months in high percentage of women
  • no risk of hyper-stimulation
  • should be used only as a last resort as long term damage unknown…..although recent study suggested better outcome than those not receiving it
  • Reduced response rate to subsequent IVF
  • The listed possibilities suggest why it may cause normal cycles in these women again for about 6 months. Long time follow-up has not been carried out and it could end up being worse for them in the long run. They also don’t respond well to subsequent IVF so should be wary (IVF is the most common referral for women with fertility problems trying to conceive, those with PCOS).
  • IVF is another possible infertility treatment. Recommended use of metformin as adjuvant to prevent OHSS which is very common in women with PCOS.
33
Q

What are alternative (non-traditional) therapies for PCOS?

A

1) Some publications on acupuncture
- Cochrane review (2011) found no randomized trials to investigate effect of acupuncture treatment for PCOS
2 Herbal preps also suggested
- Agnus castus
- Saw palmetto etc

  • There is a lot about alternative therapies, but none have undergone clinical trials and there is not much evidence for their effectiveness woman (even when desperate) should be careful not to fall for these. It is not really evidence based; it causes false hope and delays age (making it difficult to have a baby anyway) if trying for a baby (rather than treatment).
  • No known micronutrient deficiency has been identified as relevant to PCOS
34
Q

PCOS - Summary

A

1) Begins as a reproductive disorder from adolescence
- Hirsutism
- Acne
- Obesity
- Irregular cycle
- Hyperinsulinaemia
- Depression
- Anxiety

2 and 3) Preconception and pregnancy

  • Hirsutism
  • Acne
  • Obesity
  • Dyslipidaemia
  • Infertility due to oligo-or anovulation
  • Gestational diabetes, preeclampsia, preterm birth
  • Depression and anxiety
  • T2DM

4) Peri- and post-menopause
- Obesity
- T2DM
- Depression and anxiety
- CVD
- Endometrial carcinoma